Expertise in
19
conditions

Dr. Larry Kilgore

Oncology
Univ. Breast Center
1926 Alcoa Hwy Ste 410, 
Knoxville, TN 
Offers Telehealth
Expertise in
19
conditions
Univ. Breast Center
1926 Alcoa Hwy Ste 410, 
Knoxville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Larry Kilgore is an Oncologist in Knoxville, Tennessee. Dr. Kilgore is highly rated in 19 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Ovarian Cancer, Ureteroscopy, and Oophorectomy.

His clinical research consists of co-authoring 10 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Obstetrics & Gynecology in AL
Hospital Affiliations
University Health System, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Univ. Breast Center
1926 Alcoa Hwy Ste 410, Knoxville, TN 37920
Other Locations
Office
1928 Alcoa Hwy Ste 127, Knoxville, TN 37920

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: August 19, 2022
Intervention Type: Drug
Study Drug: Prexasertib
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

10 Total Publications

A Cohort Study Exploring HPV Vaccination Beliefs Among Oral Health Providers: Broadening the Scope of Education and Administration.
A Cohort Study Exploring HPV Vaccination Beliefs Among Oral Health Providers: Broadening the Scope of Education and Administration.
Journal: Vaccines
Published: October 16, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Kristopher Kimball
Oncology
Expertise in
19
conditions
Dr. Kristopher Kimball
Oncology

University Of Tennessee Medical Center

1924 Alcoa Hwy, 
Knoxville, TN 
 (0.1 miles away)
865-305-6740
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kristopher Kimball is an Oncologist in Knoxville, Tennessee. Dr. Kimball is highly rated in 19 conditions, according to our data. His top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy.

Expertise in
14
conditions
Dr. Timothy Panella
Oncology
Expertise in
14
conditions
Dr. Timothy Panella
Oncology

Office

1926 Alcoa Hwy Ste 350, 
Knoxville, TN 
 (4.6 miles away)
865-544-8780
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Panella is an Oncologist in Knoxville, Tennessee. Dr. Panella is highly rated in 14 conditions, according to our data. His top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Expertise in
28
conditions
Dr. Susan Newman
Oncology
Expertise in
28
conditions
Dr. Susan Newman
Oncology

Office

1926 Alcoa Hwy Ste 350, 
Knoxville, TN 
 (4.6 miles away)
865-544-8780
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Susan Newman is an Oncologist in Knoxville, Tennessee. Dr. Newman is highly rated in 28 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Non-Hodgkin Lymphoma, Astrocytoma, and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kilgore's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 10 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile